CDKN2A and Ewing sarcoma: If this mechanisms applies, it is likely that pRB/p16 function is only partially compromised by EWS/FLI because Ewing's Sarcomas with a deletion of p16INK4A are characterized by a more aggressive behaviour and poorer response to chemotherapy than Ewing's sarcomas with functional p16 [25].